If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing podcast@arthritis.org. Special Guest: Anna Hyde.
